POL evidenceless medicine
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „{{tp|p=32825816|t=2020. Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.|pdf=|usr=018}}“) |
|||
| Zeile 1: | Zeile 1: | ||
{{tp|p=32825816|t=2020. Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.|pdf=|usr=018}} | {{tp|p=32825816|t=2020. Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.|pdf=|usr=018}} | ||
| + | {{tp|p=32840448|t=2020. No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials.|pdf=|usr=018}} | ||
| + | {{tp|p=32840449|t=2020. The Limits of Individualism: Potential Societal Harms from the EAP for Convalescent Plasma.|pdf=|usr=019}} | ||
| + | {{tp|p=32856722|t=2020. Will evidence-based medicine be another casualty of COVID-19?|pdf=|usr=018}} | ||
| + | {{tp|p=32870059|t=2020. Will Evidence-based Medicine Survive the COVID-19 Pandemic?|pdf=|usr=018}} | ||
Version vom 17. Dezember 2020, 17:49 Uhr
32825816 2020. Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.
32840448 2020. No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials.
32840449 2020. The Limits of Individualism: Potential Societal Harms from the EAP for Convalescent Plasma.
32856722 2020. Will evidence-based medicine be another casualty of COVID-19?
32870059 2020. Will Evidence-based Medicine Survive the COVID-19 Pandemic?
